Two Sigma Investments’s Keros Therapeutics KROS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.02M	Buy	363,835 +45,396	+14%	+$701K	﹤0.01%	2169
2025 Q4	$6.48M	Buy	318,439 +235,916	+286%	+$4.14M	0.01%	1471
2025 Q3	$1.31M	Buy	82,523 +69,001	+510%	+$1.02M	﹤0.01%	2412
2025 Q2	$181K	Sell	13,522 -48,850	-78%	-$660K	﹤0.01%	2934
2025 Q1	$636K	Buy	62,372 +28,708	+85%	+$333K	﹤0.01%	2413
2024 Q4	$533K	Buy	33,664 +23,342	+226%	+$1.21M	﹤0.01%	2509
2024 Q3	$599K	Sell	10,322 -25,957	-72%	-$1.28M	﹤0.01%	2380
2024 Q2	$1.66M	Buy	36,279 +11,457	+46%	+$616K	﹤0.01%	1670
2024 Q1	$1.64M	Sell	24,822 -6,750	-21%	-$400K	﹤0.01%	1621
2023 Q4	$1.26M	Buy	+31,572	New	+$990K	﹤0.01%	1941
2022 Q3	–	Sell	-55,561	Closed	-$1.53M	–	2655
2022 Q2	$1.53M	Buy	+55,561	New	+$2.44M	0.01%	1332
2021 Q4	–	Sell	-26,404	Closed	-$1.04M	–	4687
2021 Q3	$1.04M	Sell	26,404 -2,544	-9%	-$90.5K	﹤0.01%	2579
2021 Q2	$1.23M	Buy	28,948 +20,470	+241%	+$1.11M	﹤0.01%	2300
2021 Q1	$522K	Sell	8,478 -15,999	-65%	-$1.01M	﹤0.01%	2888
2020 Q4	$1.73M	Buy	+24,477	New	+$1.54M	0.01%	1589